(Q44751936)

English

Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities

scientific article published on 11 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

author name string

Xue Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Wen-Yu Wu

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Wen-Zheng Tu

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Hai-Yan Chu

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Xiao-Xia Zhu

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Min-Rui Liang

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Yu Xue

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jiu-Cun Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

He-Jian Zou

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

11 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1501-1510

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

S100 Calgranulins in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Immunodetection of the murine chemotactic protein CP-10 in bleomycin-induced pulmonary injury.

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

The clinical relevance of autoantibodies in scleroderma

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Scleroderma--clinical and pathological advances

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

The role of the receptor for advanced glycation end-products in lung fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Phagocyte-specific S100A8/A9 Protein Levels During Disease Exacerbations and Infections in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10067-013-2305-4

21 January 2018

Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for the classification of early systemic sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma--pathophysiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23754244

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-013-2305-4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44751936&oldid=2037472709"